Patent · US Active

Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases

US11261205B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Morphochem GmbH · DE

Inventors

Thomas Kapsner · Drolshagen, DE
Axel Dalhoff · Wuppertal, DE
Thomas Gramatte · Dresden, DE

Key dates

Filing date	Jun 22, 2020
Grant date	Mar 1, 2022
Priority date	—
Expiry date	Aug 2, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.